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a b s t r a c t
Angiotensin II (AngII) is the main effector peptide of the renin–angiotensin system (RAS), and contributes
to the pathogenesis of cardiovascular disease by exerting its effects on an array of different cell types,
including central neurons. AngII intra-neuronal signaling is mediated, at least in part, by reactive oxygen
species, particularly superoxide (O2d). Recently, it has been discovered that mitochondria are a major
subcellular source of AngII-induced O2d . We have previously reported that over-expression of
manganese superoxide dismutase (MnSOD), a mitochondrial matrix-localized O2
d scavenging enzyme,
inhibits AngII intra-neuronal signaling. Interestingly, over-expression of copper/zinc superoxide dis-
mutase (CuZnSOD), which is believed to be primarily localized to the cytoplasm, similarly inhibits AngII
intra-neuronal signaling and provides protection against AngII-mediated neurogenic hypertension.
Herein, we tested the hypothesis that CuZnSOD over-expression in central neurons localizes to
mitochondria and inhibits AngII intra-neuronal signaling by scavenging mitochondrial O2d . Using a
neuronal cell culture model (CATH.a neurons), we demonstrate that both endogenous and adenovirus-
mediated over-expressed CuZnSOD (AdCuZnSOD) are present in mitochondria. Furthermore, we show
that over-expression of CuZnSOD attenuates the AngII-mediated increase in mitochondrial O2d levels
and the AngII-induced inhibition of neuronal potassium current. Taken together, these data clearly show
that over-expressed CuZnSOD in neurons localizes in mitochondria, scavenges AngII-induced mitochon-
drial O2d , and inhibits AngII intra-neuronal signaling.
& 2013 The Authors. Published by Elsevier B.V. All rights reserved.
Introduction
The brain renin–angiotensin system (RAS) plays an essential
role in the pathogenesis of hypertension [1]. Angiotensin II (AngII)
is the main effector peptide of the RAS, and elicits its pressor
response primarily through angiotensin type 1 receptors (AT1R) [2].
AT1R stimulation initiates a signaling cascade that activates NADPH
oxidases (NOX) and increases intra-cellular levels of superoxide (O2d)
[3–5]. While the importance of O2d in AngII intra-neuronal
signaling has been repeatedly and convincingly shown, the exact
mechanism of how O2d acts as an effector molecule and the
subcellular localization of its production in AngII signaling is not
fully understood.
Superoxide is formed in numerous subcellular compartments,
but recent evidence indicates a major location of AngII-induced
O2d production is the mitochondria. For example, mitochondrial
O2d has been shown to mediate both the pressor response and
sympathoexcitation induced by AngII in the rostral ventrolateral
medulla of the brain [6,7]. Additionally, we have demonstrated
that AngII-mediated mitochondrial O2d leads to the inhibition of
neuronal potassium (Kþ) current [8]. Recently, we reported that
one of the NOX isoforms (i.e. NOX4) is located in neuron mito-
chondria, and contributes to the increase in mitochondrial O2d
ﬂux after AngII stimulation [9]. Due to the signiﬁcant role
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mitochondrial O2d plays in AngII-mediated signaling, increased
scavenging of this reactive oxygen species (ROS) could prove
beneﬁcial in the treatment of AngII-mediated hypertension.
The superoxide dismutase (SOD) family of enzymes possesses
the unique ability to convert O2d to hydrogen peroxide (H2O2)
and oxygen [10]. In mammalian systems, two intra-cellular iso-
forms of SOD exist: copper/zinc (CuZnSOD) and manganese
(MnSOD). MnSOD is exclusively located within the mitochondrial
matrix, while CuZnSOD is thought to be primarily located in the
cytoplasm of cells [10]. Previous studies have demonstrated that
adenovirus-mediated over-expression of either CuZnSOD or
MnSOD in the brain decreases blood pressure in hypertensive
animal models [5,8,11,12], but how these differentially-located
enzymes elicit the same effect is unknown.
Previous studies have shown CuZnSOD to be expressed not
only in the cytoplasm, but also in the mitochondrial inter-
membrane space (MIMS) of certain cell types including neurons
[13–17]. However, the function of mitochondrial-localized CuZn-
SOD as it relates to AngII intra-neuronal signaling has not been
fully elucidated. In addition, it remains unclear if adenoviral-
mediated over-expression of CuZnSOD results in increased expres-
sion of active CuZnSOD in mitochondria. Here, we present data
demonstrating that both endogenously and adenovirus-mediated
over-expressed CuZnSOD are associated with the mitochondria of
central neurons. Furthermore, we reveal that over-expression of
CuZnSOD in neurons attenuates mitochondrial-derived O2d and
inhibition of neuronal potassium current (Ikv) in response to AngII.
Overall, this study shows the presence of active CuZnSOD in
neuron mitochondria following adenovirus-mediated gene trans-
fer, and furthers the importance of mitochondrial O2d in AngII
intra-neuronal signaling.
Methods and materials
Cell culture
Mouse catecholaminergic neurons (CATH.a cell line, ATCC
#11179), were cultured in the RPMI 1640 medium (supplemented
with 8% normal horse serum, 4% fetal bovine serum, and 1%
penicillin–streptomycin) and maintained in 5% CO2 at 37 1C. Prior
to experimentation, neurons were differentiated utilizing N6,2′-O-
dibutyryladenosine 3′,5′-cyclic monophosphate sodium salt
(1 mM, Sigma, St. Louis, MO, USA) for 6–8 days [8,18].
Adenovirus transduction
For over-expression studies, replication-deﬁcient recombinant
adenovirus (Ad5-CMV) encoding human CuZnSOD (AdCuZnSOD)
or control vector (AdEmpty) was obtained from ViraQuest Inc.
(North Liberty, IA). On day 3 of differentiation, CATH.a neurons
were transduced with 50 multiplicity of infection (MOI) of
respective virus for 24 h in serum-free media. Complete media
was replaced for an additional 4 days post-infection prior to
experimentation [19].
Immunoﬂuorescence and confocal microscopy
Differentiated and transduced CATH.a neurons were incubated
with 250 nM MitoTracker Red (Invitrogen, Molecular Probes, Carls-
bad, CA) for 20 min, as previously described [8], to localize mito-
chondria. Following this, cells were ﬁxed in 4% paraformaldehyde
and subjected to CuZnSOD immunoﬂuorescence staining. Neurons
were incubated with blocking buffer (phosphate buffer supplemen-
ted with 10% normal horse serum and 0.3% Triton X-100) for 1 h at
room temperature, then incubated with primary CuZnSOD antibody
(1:500 dilution, The Binding Site Limited, Birmingham, UK) overnight
at 4 1C. Following washout of the primary antibody, neurons were
incubated with FITC-conjugated secondary antibody (1:500 dilution,
The Binding Site Limited, Birmingham, UK) for 2 h at room tempera-
ture. Fluorescent images were acquired with a Zeiss 510 Meta
Confocal Laser Scanning Microscope.
Mitochondrial isolation
Mitochondria were isolated as previously described [8,20].
Brieﬂy, CATH.a neurons were homogenized in ice-cold buffer A
(225 mM mannitol, 65 mM sucrose, 10 mM HEPES, and 1 mM
EGTA) using a glass Dounce homogenizer. The homogenates were
centrifuged at 500g for 6 min at 4 1C to eliminate cellular debris.
The supernatant was collected and centrifuged at 10,000g for
10 min at 4 1C to obtain mitochondria-enriched pellet. This
mitochondria-enriched pellet was resuspended with ice-cold
buffer B (225 mM mannitol, 65 mM sucrose, and 10 mM HEPES),
and washed twice by centrifugation. The ﬁnal mitochondrial
fraction was subjected to standard Western blot analysis.
Western blot analysis
Immunoblotting was performed onwhole cell lysates and isolated
mitochondrial fractions. Brieﬂy, samples were separated on 4–20%
gradient pre-casted denaturing gels, followed by a transfer to
nitrocellulose membranes. After blocking, membranes were incu-
bated with primary antibody (CuZnSOD – 1:1000 dilution, Santa Cruz
Biotechnology, CA; MnSOD – 1:2000 dilution, Upstate Biotech/Milli-
pore, Billerica, MA; cytochrome c oxidase subunit IV, COXIV – 1:1000
dilution, Abcam, Cambridge, MA; lactate dehydrogenase, LDH –
1:1000 dilution, Abcam, Cambridge, MA; calnexin – 1:1000 dilution,
Abcam, Cambridge, MA) overnight at 4 1C. Following washout of
primary antibody, membranes were incubated with secondary anti-
body (1:10,000, Thermo Scientiﬁc, Rockford, IL) for 1 h at room
temperature. After addition of chemiluminescence substrate (Pierce
Enhanced Detection System, Thermo Scientiﬁc, Rockford, IL), images
were acquired by a UVP Bioimaging System.
SOD activity assay
CuZnSOD and MnSOD activity in whole cell lysates and mito-
chondrial fractions from CATH.a neurons was determined by a semi-
quantitative in-gel activity assay as previously reported [21]. Brieﬂy,
60 mg of protein was separated by electrophoresis on a 12.5% native
gel, which was then stained with 2.4 mM nitroblue tetrazolium,
28 mM riboﬂavin, and 28 mM N,N,N,N-tetramethylethylenediamine
for 20 min in dark. Following washout of the staining solution with
distilled water, the gel was illuminated under a ﬂuorescent light until
achromatic bands appeared. SOD enzymatic activity is indicated by
the intensity of achromatic bands.
Mitochondrial superoxide analysis
CATH.a neurons were incubated with MitoSOX Red (Invitrogen,
Molecular Probes, Carlsbad, CA), a O2d sensitive ﬂuorogenic
probe, and MitoTracker Green (Invitrogen, Molecular Probes,
Carlsbad, CA), a mitochondrial marker, as previously described
[8,22]. Brieﬂy, non-transduced control, AdEmpty, and AdCuZnSOD-
transduced CATH.a neurons were loaded with 1 mM of MitoSOX
Red (excitation: 405 nm and emission: 505–550 nm) for 20 min
and 50 nM of MitoTracker Green (excitation: 488 nm and emis-
sion: 575–615 nm) for 30 min. Fluorescence images were acquired
with a Zeiss 510 Meta Confocal Laser Scanning Microscope before
and after addition of 100 nM AngII for 30 min. Individual neurons
within an image were identiﬁed as a region of interest (ROI) and
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ﬂuorescence intensity from each ROI was quantiﬁed using the
Zeiss LSM 510 analysis software. AngII-induced changes in Mito-
SOX Red ﬂuorescence are reported as fold-change from baseline
(pre-AngII) ﬂuorescence.
Electrophysiological recordings
Neuronal Kþ currents (Ikv) were recorded from CATH.a neurons
using an Axopatch 200B ampliﬁer (Axon Instruments) in the
standard whole cell conﬁguration of the patch-clamp technique,
as we previously described [19,23]. Current traces were sampled at
10 kHz and ﬁltered at 5 kHz. Holding potential was 80 mV.
Current–voltage (I–V) relations were elicited by test potential over
the range of 80 to þ80 mV with 200-ms duration in 20-mV
increments. Using this protocol, we were able to measure peak Kþ
current (Ipeak), which includes the transient outward Kþ current,
and the steady-state current (Isteady-state) at the end of the 200-ms
pulse. Resulting data were acquired and analyzed with Clampﬁt
9.2 software (Axon Instruments). The effect of AngII on Ipeak and
Isteady-state was tested by superfusing CATH.a neurons with AngII
(100 nM) for 5 min and repeating the voltage pulse regimen.
Recordings were performed at 22–24 1C.
Statistical analysis
Data are presented as mean7standard error of the mean (SEM)
and were analyzed by Student's t-test for two-group comparisons or
by ANOVA followed by the Newman–Keuls correction for multiple
comparisons. GraphPad Prism 5.0 statistical and graphing software
was used. Differences were considered signiﬁcant at po0.05.
Results
Endogenously and exogenously expressed CuZnSOD are found in
neuron mitochondria
Previous reports have shown CuZnSOD expression in the inter-
membrane space of mitochondria in various cell types including
neurons [13–17]. To validate that CuZnSOD is present in the mito-
chondria of AngII-sensitive neurons, mouse catecholaminergic neuro-
nal cells (CATH.a neurons), which have been used extensively to
investigate AngII intra-neuronal signaling mechanisms, were studied.
Representative confocal microscopy images reveal co-localization of
endogenous mouse CuZnSOD with the mitochondrial-targeted ﬂuor-
escent probe MitoTracker Red (Fig. 1, top row). Furthermore, over-
expression of human CuZnSOD via adenoviral-mediated gene transfer
drastically enhances this co-localization (Fig. 1, bottom row). Taken
together, these data infer the association of CuZnSOD with mitochon-
dria in AngII-sensitive CATH.a neurons.
CuZnSOD protein and activity are found in enriched neuron
mitochondrial fractions
To further authenticate the localization and function of CuZn-
SOD in mitochondria of neurons, mitochondrial-enriched sub-
cellular fractions were isolated from CATH.a neurons. Western
blot analysis conﬁrms the purity of the mitochondrial preparation
as only MnSOD and cytochrome C oxidase subunit IV (COXIV), two
well-characterized mitochondrial-localized proteins, were
enriched in the mitochondrial fraction (Fig. 2A). In contrast,
cytosolic (i.e. lactate dehydrogenase [LDH]) and endoplasmic
reticulum (i.e. calnexin) proteins demonstrated negligible immu-
noreactivity in the mitochondrial fraction, implying a highly pure
representation of only mitochondria in the preparation (Fig. 2A).
Endogenous mouse CuZnSOD (mCuZnSOD) was shown to be
located in both the whole cell lysate and mitochondrial fraction
as determined by Western blot analysis. This distribution was
carried through to adenovirus-mediated over-expressed human
CuZnSOD (hCuZnSOD) as well (Fig. 2A). Moreover, endogenous
and exogenous (i.e. human) CuZnSOD enzymes demonstrated
activity in both the whole cell lysate and mitochondrial fraction
as indicated by the in-gel SOD activity assay (Fig. 2B). Overall,
these data strongly indicate the localization of catalytically active
CuZnSOD in mitochondria of neurons and that over-expressed
CuZnSOD protein via adenovirus transduction is robustly
expressed and active in neuron mitochondria.
Fig. 1. CuZnSOD protein expression in neuron mitochondria. Representative confocal microscopy images showing MitoTracker Red (red ﬂuorescence; left), CuZnSOD (green
ﬂuorescence; middle), and merged images (yellow with DIC; right) in control non-transduced CATH.a neurons (top row) or neurons transduced with AdCuZnSOD (50 MOI).
Arrows in merged image indicate co-localization of MitoTracker Red and CuZnSOD.
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Over-expression of CuZnSOD attenuates AngII-induced increase in
mitochondrial O2
d
We previously reported that AngII signiﬁcantly increases mito-
chondrial O2d in CATH.a neurons, and this escalation is attenuated
by over-expressing the mitochondrial-localized MnSOD [8]. Consid-
ering our new data (Figs. 1 and 2) showing that CuZnSOD is localized
in part to the mitochondria, we aimed to investigate if over-
expression of CuZnSOD could also diminish AngII-mediated mito-
chondrial O2d ﬂux. To query this, live CATH.a neurons transduced
with either AdCuZnSOD or control adenovirus (AdEmpty) were
stained with both the mitochondrially-targeted O2d-sensitive dye,
MitoSOX Red, and a ﬂuorescent mitochondrial marker, MitoTracker
Green. As expected, in AdEmpty-transduced neurons AngII stimu-
lated an increase (approximately 5.5-fold) in MitoSOX Red ﬂuores-
cence that co-localized with the MitoTracker Green ﬂuorescence,
suggesting an increase in mitochondrial O2d production (Fig. 3). In
contrast, AngII-stimulated neurons transduced with AdCuZnSOD
displayed signiﬁcantly less MitoSOX Red ﬂuorescence (Fig. 3). These
data indicate that increased activity of CuZnSOD in neuron mito-
chondria following adenoviral transduction can attenuate the AngII-
mediated increase in mitochondrial O2d levels.
CuZnSOD over-expression attenuates AngII-induced inhibition of
neuronal potassium current (Ikv)
To investigate the functional signiﬁcance of over-expressing
CuZnSOD in neuron mitochondria, whole-cell patch-clamping to
elucidate AngII-induced changes in Ikv was performed on AdCuZnSOD-
transduced CATH.a neurons. As previously reported [8], AngII
signiﬁcantly decreased outward Ipeak and Isteady-state in non-
transduced control neurons and neurons transduced with
AdEmpty (Fig. 4). In contrast, this attenuation in Ikv was signiﬁ-
cantly inhibited in CATH.a neurons over-expressing CuZnSOD
(Fig. 4). Taken together, these data indicate that increased expres-
sion of active CuZnSOD in neuron mitochondria via adenovirus-
mediated gene transfer is sufﬁcient to offset AngII-mediated intra-
neuronal signaling and downstream physiological endpoints.
Discussion
In the present study, we conﬁrm the observation of endogen-
ous CuZnSOD localization to the mitochondria of neurons. Further-
more, we found that over-expression of CuZnSOD via adenoviral
transduction signiﬁcantly increases the levels of active CuZnSOD in
neuron mitochondria. This increased expression of CuZnSOD in
mitochondria attenuated AngII-mediated increases in mitochon-
drial O2d and the AngII-induced inhibition of Ikv. We have
previously reported similar ﬁndings by over-expressing MnSOD
[8], which extends the importance of mitochondrial O2d in AngII-
mediated signaling. While CuZnSOD activity is canonically thought
to be cytoplasmic in origin, our data presented here suggest a
functional role for the antioxidant enzyme at a speciﬁc subcellular
organelle. Most importantly, our ﬁndings challenge previous
interpretations of AdCuZnSOD inhibiting AngII intra-cellular sig-
naling because of its ability to scavenge only cytoplasmic O2d ,
and suggest that CuZnSOD over-expression may inhibit AngII
signaling because of its ability to scavenge mitochondrial-
localized O2d .
Reactive oxygen species (ROS) are critical mediators of cellular
signaling, and one speciﬁc ROS, O2d , has been demonstrated as a
main effector molecule in AngII intra-neuronal signaling
[4,5,24,25]. One established mechanism of increased O2d in
neurons in response to AngII is NADPH oxidase activation
[26,27]. We have recently shown that NADPH oxidase 4 (NOX4)
is located in neuron mitochondria, and is a source of O2d in
response to AngII [9]. While NOX4 may be a source of AngII-
mediated O2d in neuron mitochondria, other sources of mito-
chondrial O2d have also been proposed. A secondary source of
mitochondrial O2d may derive from the opening of mitochondrial
KATP channels (mitoKATP). mitoKATP have shown to be activated in
the presence of O2d , which would occur during time of increased
NOX activation and could lead to aberrant mitochondrial function
due to electron leakage from complexes I and III [28]. Another
source of mitochondrial O2d can be from the mitochondrial
permeability transition (MPT). Similar to the mitoKATP channels,
the MPT has been shown to be sensitive to ROS as well as calcium
[29]. The opening of the MPT pore alters mitochondrial metabo-
lism and function, and thus creates a viscous cycle of ROS
generation following a preliminary ROS stimulus, which may be
initiated by AngII and the NOX family of enzymes. Interestingly,
while numerous sources of mitochondrial O2d have been identi-
ﬁed as potential manufacturers of the AngII-mediated ROS, very
little is known about the O2d spatial location within the mito-
chondria. O2d produced on the matrix side of the mitochondria
may exert very different effects from O2d produced in the inter-
membrane space. Understanding of the spatial O2d production in
mitochondria may be critical in AngII-mediated intra-neuronal
signaling, and thus further studies are warranted to fully elucidate
the speciﬁc origins of the O2d in response to AngII.
CuZnSOD was ﬁrst identiﬁed in the MIMS by Irwin Fridovich in
1973 [17], but how CuZnSOD is transported into the MIMS has
remained elusive. CuZnSOD requires disulﬁde formation as well as
copper insertion that are performed by the copper chaperone for
SOD1 (CCS) [30,31]. Interestingly, CuZnSOD has been shown to
Fig. 2. Adenovirus-mediated over-expression of CuZnSOD in CATH.a neurons results
in expression of active CuZnSOD in mitochondria. (A) Representative Western blot
analysis showing CuZnSOD protein expression in whole cell lysates and mitochondrial
fractions collected from control non-transduced, AdEmpty-transduced, or AdCuZnSOD-
transduced CATH.a neurons. Adenovirus-expressed human CuZnSOD (hCuZnSOD) is
distinguishable from endogenous mouse CuZnSOD (mCuZnSOD). Robust immunor-
eactivity of mitochondrial markers (MnSOD, COXIV) and lack of immunoreactivity
of cytoplasmic (lactate dehydrogenase, LDH) and endoplasmic reticulum (calnexin)
markers in the mitochondrial fraction indicate purity of mitochondrial preparation.
(B) Representative in-gel SOD activity assay showing activity of MnSOD, endogen-
ous mouse CuZnSOD, and adenovirus-mediated expressed human CuZnSOD in
whole cell lysates and mitochondrial fractions collected from non-transduced,
AdEmpty-transduced, or AdCuZnSOD-transduced CATH.a neurons.
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only be able to cross the outer membrane of the mitochondria in
its non-metallated and reduced state [32], which means that
maturation of CuZnSOD must occur within the mitochondria.
The most current proposed mechanism of CuZnSOD translocation
is dependent upon the Erv1/Mia40 disulﬁde relay system, where
CCS facilitates the folding, copper insertion, and trapping of
CuZnSOD in the MIMS [33]. Recently, Kawamata and Manfredi
identiﬁed that oxygen tension also affects the import of CuZnSOD
to the mitochondria. They demonstrated that 20% oxygen inhib-
ited while 6% oxygen augmented the import of CuZnSOD to the
mitochondria [34]. One explanation for this phenomenon could be
that in low oxygen tensions, electrons may leak from the electron
transport chain at a higher rate due to a lack of molecular oxygen
as a ﬁnal acceptor, which causes increases in mitochondrial O2d
production. The increase in CuZnSOD in the MIMS may be a
preventative measure in the counteracting of any potential
damage or signaling that could arise from this change in oxygen
tension. Overall, while the mechanisms for CuZnSOD translocation
to the mitochondria are not fully understood, the amount of
energy and cellular machinery involved in transporting CuZnSOD
into the mitochondria suggests this is an important and vital
cellular process. In the current study, we demonstrate that over-
expression of CuZnSOD has the ability to attenuate AngII-mediated
increases in mitochondrial O2d levels. We did not examine
if endogenous CuZnSOD mitochondrial import was increased
during AngII stimulation, as a potential regulatory mechanism
for the increased mitochondrial O2d production. Additionally, our
experiments were performed at 21% oxygen, which may limit the
amount of CuZnSOD (both exogenous and endogenous) imported
to the mitochondria. In summary, the data presented here demon-
strate a novel function for over-expressed CuZnSOD in the
attenuation of AngII-mediated mitochondrial O2d ﬂux in neu-
rons, but more work is necessary to fully elucidate the mechanism
of this process.
Fig. 3. Over-expressed CuZnSOD attenuates AngII-induced increases in mitochondrial O2d levels. (A) High magniﬁcation confocal microscopy images showing baseline
MitoSOX Red oxidation (red ﬂuorescence; far left), MitoSOX Red oxidation after 20 min of 100 nM AngII stimulation (red ﬂuorescence; middle left), MitoTracker Green (green
ﬂuorescence; middle right), and merged images (yellow with DIC; far right) in CATH.a neurons following adenoviral transduction (50 MOI) of either CuZnSOD (AdCuZnSOD)
or vector control (AdEmpty). (B) Quantiﬁcation of MitoSOX Red ﬂuorescence intensity from confocal images using Zeiss Confocal LSM analysis software. Fluorescence
intensity was normalized to baseline MitoSOX red ﬂuorescence in each neuron (n¼32 neurons for AdEmpty; n¼46 neurons for AdCuZnSOD). *po0.05 versus baseline
ﬂuorescence; #po0.05 versus AdEmpty.
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In conclusion, our present study has demonstrated that over-
expression of CuZnSOD via adenovirus-mediated gene transfer in
neurons signiﬁcantly increases both mitochondrial CuZnSOD pro-
tein level and enzyme activity. Additionally, the over-expressed
CuZnSOD is able to attenuate the increased mitochondrial O2d
levels observed after AngII stimulation, which prevents AngII-
induced inhibition of Ikv. These data suggest that mitochondrial-
produced O2d plays a signiﬁcant role in AngII-mediated neuronal
signaling, and that over-expression of CuZnSOD has the ability to
diminish these effects. Furthermore, these data challenge the
interpretation of previous studies that CuZnSOD over-expression
via adenoviral transduction inhibits AngII intra-cellular signaling
because it scavenges only cytoplasmic O2d . Our ﬁndings suggest
that inhibition of AngII signaling via CuZnSOD over-expression
may be due to its mitochondrial localization and ability to
scavenge mitochondrial O2d .
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